3,102 results on '"Cerhan, James R."'
Search Results
202. The Non-Hodgkin Lymphomas
203. Genetics in Lymphomagenesis
204. Two high-risk susceptibility loci at 6p25.3 and 14q32.13 for Waldenström macroglobulinemia
205. Loss of TNFAIP3 enhances MYD88L265P-driven signaling in non-Hodgkin lymphoma
206. Differences in genomic abnormalities among African individuals with monoclonal gammopathies using calculated ancestry
207. History of autoimmune conditions and lymphoma prognosis
208. Defining cure in multiple myeloma: a comparative study of outcomes of young individuals with myeloma and curable hematologic malignancies
209. Estimating mixture effects and cumulative spatial risk over time simultaneously using a Bayesian index low‐rank kriging multiple membership model
210. Revised MALT‐IPI: A new predictive model that identifies high‐risk patients with extranodal marginal zone lymphoma
211. Physical activity and the risk of non‐Hodgkin lymphoma subtypes: A pooled analysis
212. Patient Experience in Clinical Trials: Quality of Life, Financial Burden, and Perception of Care in Patients With Multiple Myeloma or Lymphoma Enrolled on Clinical Trials Compared With Standard Care
213. Cytokine gene polymorphisms and progression-free survival in classical Hodgkin lymphoma by EBV status: Results from two independent cohorts
214. Patients With Heart Failure Have an Increased Risk of Incident Cancer
215. Hospitalizations and Emergency Department Use in Mayo Clinic Biobank Participants Within the Employee and Community Health Medical Home
216. The Mayo Clinic Biobank: A Building Block for Individualized Medicine
217. Risk of adult acute and chronic myeloid leukemia with cigarette smoking and cessation
218. The significance of gradient expression of chromosome region maintenance protein 1 in large cell lymphoma
219. Household endotoxin levels and the risk of non-Hodgkin lymphoma
220. Smoking, variation in N-acetyltransferase 1 (NAT1) and 2 (NAT2), and risk of non-Hodgkin lymphoma: a pooled analysis within the InterLymph consortium
221. Distinct germline genetic susceptibility profiles identified for common non-Hodgkin lymphoma subtypes
222. Distinct germline genetic susceptibility profiles identified for common non-Hodgkin lymphoma subtypes
223. Distinct germline genetic susceptibility profiles identified for common non-Hodgkin lymphoma subtypes
224. B-Cell NHL Subtype Risk Associated with Autoimmune Conditions and PRS
225. Cohort Profile: The Lymphoma Specialized Program of Research Excellence (SPORE) Molecular Epidemiology Resource (MER) Cohort Study
226. Risk of cutaneous T‐cell lymphoma in patients with chronic lymphocytic leukemia and other subtypes of non‐Hodgkin lymphoma
227. Clinical heterogeneity of diffuse large B cell lymphoma following failure of front‐line immunochemotherapy
228. Germline genetic variation in JAK2 as a prognostic marker in castration‐resistant prostate cancer
229. The association between early life and adult body mass index and physical activity with risk of non-Hodgkin lymphoma: impact of gender
230. Pretreatment circulating serum cytokines associated with follicular and diffuse large B-cell lymphoma: A clinic-based case-control study
231. Incidence of Monoclonal Gammopathy of Undetermined Significance and Estimation of Duration Before First Clinical Recognition
232. Early life sun exposure, vitamin D-related gene variants, and risk of non-Hodgkin lymphoma
233. Medical conditions and risk of adult myeloid leukemia
234. Discovery and prioritization of somatic mutations in diffuse large B-cell lymphoma (DLBCL) by whole-exome sequencing
235. Germline Predictors of Androgen Deprivation Therapy Response in Advanced Prostate Cancer
236. A genome-wide meta-analysis of nodular sclerosing Hodgkin lymphoma identifies risk loci at 6p21.32
237. Abstract 741: Evaluation of etiologic heterogeneity for risk of diffuse large B-cell lymphoma (DLBCL) subtype defined by cell-of-origin
238. Abstract 5256: Incidence of squamous cell carcinoma (SCC) in a large screening cohort of monoclonal B-cell lymphocytosis (MBL)
239. Computational drug repurposing based on electronic health records: a scoping review
240. Long-Term Health-Related Quality of Life of Autologous Hematopoietic Cell Transplantation Patients and Nontransplant Patients With Aggressive Lymphoma: A Prospective Cohort Analysis
241. A (modifiable) way to better Hodgkin lymphoma survivorship?
242. PET2 response associated with survival in newly diagnosed diffuse large B-cell lymphoma: results of two independent prospective cohorts
243. A Case-Control Study of Occupational Exposure to Trichloroethylene and Non-Hodgkin Lymphoma
244. Revised MALT-IPI: A new predictive model that identifies high-risk patients with extranodal marginal zone lymphoma
245. A case-control study of tobacco use and other non-occupational risk factors for lymphoma subtypes defined by t (14; 18) translocations and bcl-2 expression
246. Nitrate Intake and the Risk of Thyroid Cancer and Thyroid Disease
247. Author Correction: Molecular subtypes of diffuse large B cell lymphoma are associated with distinct pathogenic mechanisms and outcomes
248. ARE THERE ANY SEX-BASED DISPARITIES IN THE DEVELOPMENT OF HEART FAILURE OR CARDIOTOXICITY IN LYMPHOMA PATIENTS TREATED WITH ANTHRACYCLINES?
249. ASSOCIATION OF ANTHRACYCLINES WITH MAJOR ADVERSE CARDIOVASCULAR EVENTS (MACE) IN PATIENTS TREATED FOR BREAST CANCER OR LYMPHOMA AFTER 30 YEARS OF FOLLOW UP
250. Relationship between Interferon Regulatory Factor 4 Genetic Polymorphisms, Measures of Sun Sensitivity and Risk for Non-Hodgkin Lymphoma
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.